Kenai Therapeutics Secures $82M in Series A Funding
Key Highlights $82 million Series A funding co-led by prestigious investors to fuel Kenai’s innovative approach to neurodegenerative diseases.…
Browsing Tag
Tomoyuki Hasegawa
1 post